BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, Witte K, Kunz S, Buss A, Roewert HJ, Krause M. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol. 2011;186:1228-1239. [PMID: 21148041 DOI: 10.4049/jimmunol.0903907] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Sabat R. [Acne inversa/hidradenitis suppurativa: A challenge for the future]. Hautarzt 2017;68:994-8. [PMID: 29110042 DOI: 10.1007/s00105-017-4079-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Witte E, Kokolakis G, Witte K, Philipp S, Doecke WD, Babel N, Wittig BM, Warszawska K, Kurek A, Erdmann-Keding M, Kunz S, Asadullah K, Kadin ME, Volk HD, Sterry W, Wolk K, Sabat R. IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis. J Invest Dermatol 2014;134:2757-67. [PMID: 25046339 DOI: 10.1038/jid.2014.308] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 13.3] [Reference Citation Analysis]
3 Kelly G, Prens EP. Inflammatory Mechanisms in Hidradenitis Suppurativa. Dermatol Clin 2016;34:51-8. [PMID: 26617358 DOI: 10.1016/j.det.2015.08.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 7.6] [Reference Citation Analysis]
4 Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: An update. J Am Acad Dermatol 2015;73:S8-11. [PMID: 26470623 DOI: 10.1016/j.jaad.2015.07.045] [Cited by in Crossref: 113] [Cited by in F6Publishing: 85] [Article Influence: 22.6] [Reference Citation Analysis]
5 Kato-Kogoe N, Nishioka T, Kawabe M, Kataoka F, Yamanegi K, Yamada N, Hata M, Yamamoto T, Nakasho K, Urade M, Terada N, Ohyama H. The promotional effect of IL-22 on mineralization activity of periodontal ligament cells. Cytokine 2012;59:41-8. [PMID: 22537848 DOI: 10.1016/j.cyto.2012.03.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
6 Jemec G. Predicting response to anti- TNF -alpha treatment in Hidradenitis suppurativa. British Journal of Dermatology 2013;168:233-233. [DOI: 10.1111/bjd.12192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Kelly G, Sweeney CM, Tobin AM, Kirby B. Hidradenitis suppurativa: the role of immune dysregulation. Int J Dermatol. 2014;53:1186-1196. [PMID: 24961484 DOI: 10.1111/ijd.12550] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
8 Alegre ML, Chen L, David MZ, Bartman C, Boyle-Vavra S, Kumar N, Chong AS, Daum RS. Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans. J Immunol 2016;197:1118-26. [PMID: 27402695 DOI: 10.4049/jimmunol.1600549] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
9 Riverain-gillet É, Guet-revillet H, Jais J, Ungeheuer M, Duchatelet S, Delage M, Lam T, Hovnanian A, Nassif A, Join-lambert O. The Surface Microbiome of Clinically Unaffected Skinfolds in Hidradenitis Suppurativa: A Cross-Sectional Culture-Based and 16S rRNA Gene Amplicon Sequencing Study in 60 Patients. Journal of Investigative Dermatology 2020;140:1847-1855.e6. [DOI: 10.1016/j.jid.2020.02.046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 15.0] [Reference Citation Analysis]
10 Giot JP, Paris I, Levillain P, Huguier V, Charreau S, Delwail A, Garcia M, Garnier J, Bernard FX, Dagregorio G, Guillet G, Morel F, Lecron JC, Favot L. Involvement of IL-1 and oncostatin M in acanthosis associated with hypertensive leg ulcer. Am J Pathol 2013;182:806-18. [PMID: 23313749 DOI: 10.1016/j.ajpath.2012.11.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
11 Guillet A, Brocard A, Bach Ngohou K, Graveline N, Leloup AG, Ali D, Nguyen JM, Loirat MJ, Chevalier C, Khammari A, Dreno B. Verneuil's disease, innate immunity and vitamin D: a pilot study. J Eur Acad Dermatol Venereol 2015;29:1347-53. [PMID: 25512084 DOI: 10.1111/jdv.12857] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
12 Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 2012;7:e31810. [PMID: 22359634 DOI: 10.1371/journal.pone.0031810] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 13.4] [Reference Citation Analysis]
13 Witte-Händel E, Wolk K, Tsaousi A, Irmer ML, Mößner R, Shomroni O, Lingner T, Witte K, Kunkel D, Salinas G, Jodl S, Schmidt N, Sterry W, Volk HD, Giamarellos-Bourboulis EJ, Pokrywka A, Döcke WD, Schneider-Burrus S, Sabat R. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction. J Invest Dermatol 2019;139:1294-305. [PMID: 30528824 DOI: 10.1016/j.jid.2018.11.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 18.0] [Reference Citation Analysis]
14 Kelly G, Hughes R, McGarry T, van den Born M, Adamzik K, Fitzgerald R, Lawlor C, Tobin AM, Sweeney CM, Kirby B. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. Br J Dermatol. 2015;173:1431-1439. [PMID: 26282467 DOI: 10.1111/bjd.14075] [Cited by in Crossref: 118] [Cited by in F6Publishing: 99] [Article Influence: 19.7] [Reference Citation Analysis]
15 Wollina U, Koch A, Heinig B, Kittner T, Nowak A. Acne inversa (Hidradenitis suppurativa): A review with a focus on pathogenesis and treatment. Indian Dermatol Online J 2013;4:2-11. [PMID: 23439959 DOI: 10.4103/2229-5178.105454] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
16 Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr 2016;21:184-98. [PMID: 26307347 DOI: 10.1017/S1092852915000449] [Cited by in Crossref: 89] [Cited by in F6Publishing: 36] [Article Influence: 14.8] [Reference Citation Analysis]
17 Sabat R, Wolk K. Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis. J Dtsch Dermatol Ges 2011;9:518-23. [PMID: 21251229 DOI: 10.1111/j.1610-0387.2011.07611.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
18 Wittmann M, Mcgonagle D, Werfel T. Cytokines as therapeutic targets in skin inflammation. Cytokine & Growth Factor Reviews 2014;25:443-51. [DOI: 10.1016/j.cytogfr.2014.07.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
19 Rothenberg ME, Wang Y, Lekkerkerker A, Danilenko DM, Maciuca R, Erickson R, Herman A, Stefanich E, Lu TT. Randomized Phase I Healthy Volunteer Study of UTTR 1147A ( IL ‐22Fc): A Potential Therapy for Epithelial Injury. Clin Pharmacol Ther 2018;105:177-89. [DOI: 10.1002/cpt.1164] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
20 Tripathi D, Venkatasubramanian S, Cheekatla SS, Paidipally P, Welch E, Tvinnereim AR, Vankayalapati R. A TLR9 agonist promotes IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice. Nat Commun 2016;7:13896. [PMID: 27982034 DOI: 10.1038/ncomms13896] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
21 Shah A, Alhusayen R, Amini-Nik S. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflamm Res 2017;66:931-45. [PMID: 28656364 DOI: 10.1007/s00011-017-1074-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
22 Sabat R, Wolk K, Loyal L, Döcke WD, Ghoreschi K. T cell pathology in skin inflammation. Semin Immunopathol 2019;41:359-77. [PMID: 31028434 DOI: 10.1007/s00281-019-00742-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 21.5] [Reference Citation Analysis]
23 Martorell A, García-martínez F, Jiménez-gallo D, Pascual J, Pereyra-rodriguez J, Salgado L, Vilarrasa E. Actualización en hidradenitis supurativa (I): epidemiología, aspectos clínicos y definición de severidad de la enfermedad. Actas Dermo-Sifiliográficas 2015;106:703-15. [DOI: 10.1016/j.ad.2015.06.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
24 Nikolakis G, Kokolakis G, Kaleta K, Wolk K, Hunger R, Sabat R, Zouboulis CC. [Pathogenesis of hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:658-65. [PMID: 34228138 DOI: 10.1007/s00105-021-04853-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Thomi R, Cazzaniga S, Seyed Jafari SM, Schlapbach C, Hunger RE. Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis. JAMA Dermatol 2018;154:592-5. [PMID: 29617527 DOI: 10.1001/jamadermatol.2018.0141] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
26 Gill L, Williams M, Hamzavi I. Update on hidradenitis suppurativa: connecting the tracts. F1000Prime Rep 2014;6:112. [PMID: 25580266 DOI: 10.12703/P6-112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
27 Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, Lapins J, Matusiak L, Prens EP, Revuz J. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619-644. [PMID: 25640693 DOI: 10.1111/jdv.12966] [Cited by in Crossref: 453] [Cited by in F6Publishing: 316] [Article Influence: 75.5] [Reference Citation Analysis]
28 Shanmugam VK, Jones D, Mcnish S, Bendall ML, Crandall KA. Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis. Clin Exp Dermatol 2019;44:882-92. [DOI: 10.1111/ced.13959] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
29 Jones D, Banerjee A, Berger PZ, Gross A, McNish S, Amdur R, Shanmugam VK. Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis. Immunol Invest 2018;47:57-70. [PMID: 28972431 DOI: 10.1080/08820139.2017.1377227] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
30 Xu J, Liu X, Gao B, Karin M, Tsukamoto H, Brenner D, Kisseleva T. New Approaches for Studying Alcoholic Liver Disease. Curr Pathobiol Rep 2014;2:171-83. [PMID: 26594598 DOI: 10.1007/s40139-014-0053-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
31 Wieland C, Vogl T, Ordelman A, Vloedgraven H, Verwoolde L, Rensen J, Roth J, Boer J, Hessels J. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?: S100A8/A9, a novel biomarker for hidradenitis suppurativa. British Journal of Dermatology 2013;168:1252-8. [DOI: 10.1111/bjd.12234] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
32 Mulcahy ME, Leech JM, Renauld JC, Mills KH, McLoughlin RM. Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa. Mucosal Immunol 2016;9:1429-41. [PMID: 27007677 DOI: 10.1038/mi.2016.24] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
33 Smith MK, Nicholson CL, Parks-Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017;6:1272. [PMID: 28794864 DOI: 10.12688/f1000research.11337.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
34 Mckinnon LR, Kaul R. Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Current Opinion in HIV and AIDS 2012;7:195-202. [DOI: 10.1097/coh.0b013e3283504941] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 7.8] [Reference Citation Analysis]
35 Blok J, van Hattem S, Jonkman M, Horváth B. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review: Systemic immunosuppressive therapy and retinoids for HS. British Journal of Dermatology 2013;168:243-52. [DOI: 10.1111/bjd.12104] [Cited by in Crossref: 75] [Cited by in F6Publishing: 52] [Article Influence: 9.4] [Reference Citation Analysis]
36 Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidence. JAAD Int 2020;1:62-72. [PMID: 34409324 DOI: 10.1016/j.jdin.2020.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
37 Thomi R, Yerly D, Yawalkar N, Simon D, Schlapbach C, Hunger RE. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa. Br J Dermatol 2017;177:1358-66. [PMID: 28301691 DOI: 10.1111/bjd.15458] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
38 Schell SL, Schneider AM, Nelson AM. Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa. Exp Dermatol 2021. [PMID: 34018644 DOI: 10.1111/exd.14398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Rosales Santillan M, Morss PC, Porter ML, Kimball AB. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther 2020;20:621-33. [PMID: 32077334 DOI: 10.1080/14712598.2020.1732918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Krause K, Sabat R, Witte-Händel E, Schulze A, Puhl V, Maurer M, Wolk K. Association of CCL2 with systemic inflammation in Schnitzler syndrome. Br J Dermatol 2019;180:859-68. [PMID: 30339714 DOI: 10.1111/bjd.17334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
41 Yao Y, Ravn Jørgensen A, Thomsen SF. Biologics for chronic inflammatory skin diseases: an update for the clinician. Journal of Dermatological Treatment 2020;31:108-30. [DOI: 10.1080/09546634.2019.1589643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
42 Wolk K, Witte K, Witte E, Raftery M, Kokolakis G, Philipp S, Schönrich G, Warszawska K, Kirsch S, Prösch S, Sterry W, Volk HD, Sabat R. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med 2013;5:204ra129. [PMID: 24068736 DOI: 10.1126/scitranslmed.3006245] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 11.7] [Reference Citation Analysis]
43 von Laffert M, Hunger RE, Navarini AA, Zouboulis CC. [Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:666-75. [PMID: 34213572 DOI: 10.1007/s00105-021-04848-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Vural S, Gundogdu M, Kundakci N, Ruzicka T. Familial Mediterranean fever patients with hidradenitis suppurativa. Int J Dermatol 2017;56:660-3. [DOI: 10.1111/ijd.13503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
45 Sabat R, Witte E, Witte K, Wolk K. IL-22 and IL-17: An Overview. In: Quesniaux V, Ryffel B, Padova F, editors. IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity. Basel: Springer; 2013. pp. 11-35. [DOI: 10.1007/978-3-0348-0522-3_2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
46 Pink A, Anzengruber F, Navarini A. Acne and hidradenitis suppurativa. Br J Dermatol 2018;178:619-31. [DOI: 10.1111/bjd.16231] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
47 Yidana DB. Hidradenitis suppurativa - The role of interleukin-17, the aryl hydrocarbon receptor and the link to a possible fungal aetiology. Med Hypotheses 2021;149:110530. [PMID: 33607406 DOI: 10.1016/j.mehy.2021.110530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Witte E, Kokolakis G, Witte K, Warszawska K, Friedrich M, Christou D, Kirsch S, Sterry W, Volk HD, Sabat R, Wolk K. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. J Mol Med (Berl) 2016;94:391-400. [PMID: 26612594 DOI: 10.1007/s00109-015-1367-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
49 Witte K, Koch E, Volk HD, Wolk K, Sabat R. The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells. J Mol Med (Berl) 2020;98:1493-503. [PMID: 32948884 DOI: 10.1007/s00109-020-01970-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ, Jemec GBE, Del Marmol V, Marzano AV, Nikolakis G, Sayed CJ, Tzellos T, Wolk K, Prens EP. Target molecules for future hidradenitis suppurativa treatment. Exp Dermatol 2021;30 Suppl 1:8-17. [PMID: 34085329 DOI: 10.1111/exd.14338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
51 Arshad T, Mansur F, Palek R, Manzoor S, Liska V. A Double Edged Sword Role of Interleukin-22 in Wound Healing and Tissue Regeneration. Front Immunol 2020;11:2148. [PMID: 33042126 DOI: 10.3389/fimmu.2020.02148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Martin JC, Wolk K, Bériou G, Abidi A, Witte-händel E, Louvet C, Kokolakis G, Drujont L, Dumoutier L, Renauld J, Sabat R, Josien R. Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation. J I 2017;198:3671-8. [DOI: 10.4049/jimmunol.1700021] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
53 Melnik B, Plewig G. Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa): Correspondence. British Journal of Dermatology 2013;168:876-8. [DOI: 10.1111/bjd.12068] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
54 Falola RA, Defazio MV, Anghel EL, Mitnick CDB, Attinger CE, Evans KK. What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? Plastic and Reconstructive Surgery 2016;138:219S-29S. [DOI: 10.1097/prs.0000000000002671] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 3.2] [Reference Citation Analysis]
55 Jørgensen AR, Aarestrup J, Baker JL, Thomsen SF. Association of Birth Weight, Childhood Body Mass Index, and Height With Risk of Hidradenitis Suppurativa. JAMA Dermatol 2020;156:746-53. [PMID: 32347905 DOI: 10.1001/jamadermatol.2020.1047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
56 Wolk K, Wenzel J, Tsaousi A, Witte-Händel E, Babel N, Zelenak C, Volk HD, Sterry W, Schneider-Burrus S, Sabat R. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa. Br J Dermatol 2017;177:1385-93. [PMID: 28256718 DOI: 10.1111/bjd.15424] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
57 Constantinou CA, Fragoulis GE, Nikiphorou E. Hidradenitis suppurativa: infection, autoimmunity, or both? Ther Adv Musculoskelet Dis 2019;11:1759720X19895488. [PMID: 31908656 DOI: 10.1177/1759720X19895488] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Chi HG, Zheng XB, Wu ZG, Dai SX, Wan Z, Zou Y. Association of the interleukin-22 genetic polymorphisms with ulcerative colitis. Diagn Pathol 2014;9:183. [PMID: 25297677 DOI: 10.1186/s13000-014-0183-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
59 Riis PT, Ring HC, Kjaersgaard Andersen R, Jemec GB. Self-reported minor infections in patients with hidradenitis suppurativa and healthy controls. Clin Exp Dermatol 2018;43:144-8. [DOI: 10.1111/ced.13278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Sabat R, Wolk K. Role of IL-23, IL-17, and IL-22 in Psoriasis. In: Quesniaux V, Ryffel B, Padova F, editors. IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity. Basel: Springer; 2013. pp. 287-304. [DOI: 10.1007/978-3-0348-0522-3_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Hiraiwa T, Hanami Y, Yamamoto T. Hidradenitis suppurativa and multiple dermatofibromas in a patient with ulcerative colitis. J Dermatol. 2013;40:1071-1072. [PMID: 24330184 DOI: 10.1111/1346-8138.12316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Woodruff CM, Charlie AM, Leslie KS. Hidradenitis Suppurativa. Mayo Clinic Proceedings 2015;90:1679-93. [DOI: 10.1016/j.mayocp.2015.08.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
63 Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 2014;13:21-38. [PMID: 24378801 DOI: 10.1038/nrd4176] [Cited by in Crossref: 337] [Cited by in F6Publishing: 304] [Article Influence: 48.1] [Reference Citation Analysis]
64 Liu YS, Huang H, Zhou SM, Tian HJ, Li P. Excessive Iron Availability Caused by Disorders of Interleukin-10 and Interleukin-22 Contributes to High Altitude Polycythemia. Front Physiol 2018;9:548. [PMID: 29872401 DOI: 10.3389/fphys.2018.00548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
65 Rademacher F, Gläser R, Harder J. Antimicrobial peptides and proteins: Interaction with the skin microbiota. Exp Dermatol 2021. [PMID: 34310774 DOI: 10.1111/exd.14433] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Theut Riis P, Thorlacius LR, Jemec GB. Investigational drugs in clinical trials for Hidradenitis Suppurativa. Expert Opin Investig Drugs 2018;27:43-53. [PMID: 29188733 DOI: 10.1080/13543784.2018.1412430] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
67 Vossen ARJV, Ardon CB, van der Zee HH, Lubberts E, Prens EP. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Br J Dermatol 2019;181:314-23. [PMID: 30657173 DOI: 10.1111/bjd.17641] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
68 Moran B, Sweeney CM, Hughes R, Malara A, Kirthi S, Tobin AM, Kirby B, Fletcher JM. Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy. J Invest Dermatol 2017;137:2389-95. [PMID: 28652108 DOI: 10.1016/j.jid.2017.05.033] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 19.3] [Reference Citation Analysis]
69 Minakawa S, Matsuzaki Y, Rokunohe D, Kumagai N, Kurose A, Kushibiki M, Kayaba H, Sawamura D. Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody. Clin Exp Dermatol 2021. [PMID: 34096639 DOI: 10.1111/ced.14789] [Reference Citation Analysis]
70 Schneider-Burrus S, Arpa E, Kors C, Stavermann T, Sabat R, Kokolakis G. [Drug therapy of acne inversa]. Hautarzt 2018;69:58-63. [PMID: 29234829 DOI: 10.1007/s00105-017-4094-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Chan LC, Chaili S, Filler SG, Miller LS, Solis NV, Wang H, Johnson CW, Lee HK, Diaz LF, Yeaman MR. Innate Immune Memory Contributes to Host Defense against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus. Infect Immun 2017;85:e00876-16. [PMID: 27849182 DOI: 10.1128/IAI.00876-16] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
72 Navrazhina K, Garcet S, Frew JW, Zheng X, Coats I, Guttman-Yassky E, Krueger JG. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris. J Am Acad Dermatol 2021:S0190-9622(21)02187-3. [PMID: 34339761 DOI: 10.1016/j.jaad.2021.07.035] [Reference Citation Analysis]
73 Sabat R, Tsaousi A, Rossbacher J, Kurzen H, Fadai T, Schwichtenberg U, Schneider-Burrus S, Kokolakis G, Wolk K. [Acne inversa/hidradenitis suppurativa: An update]. Hautarzt 2017;68:999-1006. [PMID: 29159469 DOI: 10.1007/s00105-017-4082-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
74 Witte K, Koch E, Volk HD, Wolk K, Sabat R. The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes. PLoS One 2015;10:e0138075. [PMID: 26406906 DOI: 10.1371/journal.pone.0138075] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
75 Thomi R, Kakeda M, Yawalkar N, Schlapbach C, Hunger RE. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2017;31:2091-6. [PMID: 28602023 DOI: 10.1111/jdv.14389] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
76 Zhao X, Zhu D, Ye J, Li X, Wang Z, Zhang L, Xu W. The potential protective role of the combination of IL-22 and TNF-α against genital tract Chlamydia trachomatis infection. Cytokine 2015;73:66-73. [PMID: 25734538 DOI: 10.1016/j.cyto.2015.01.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
77 Hofmann SC, Saborowski V, Lange S, Kern WV, Bruckner-tuderman L, Rieg S. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa. Journal of the American Academy of Dermatology 2012;66:966-74. [DOI: 10.1016/j.jaad.2011.07.020] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
78 Kashetsky N, Mufti A, Alabdulrazzaq S, Lytvyn Y, Sachdeva M, Rahat A, Yeung J. Treatment Outcomes of IL-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review. J Cutan Med Surg 2021;:12034754211035667. [PMID: 34365863 DOI: 10.1177/12034754211035667] [Reference Citation Analysis]
79 Gratton R, Tricarico PM, d'Adamo AP, Bianco AM, Moura R, Agrelli A, Brandão L, Zupin L, Crovella S. Notch Signaling Regulation in Autoinflammatory Diseases. Int J Mol Sci 2020;21:E8847. [PMID: 33238371 DOI: 10.3390/ijms21228847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Guenin-Macé L, Morel JD, Doisne JM, Schiavo A, Boulet L, Mayau V, Goncalves P, Duchatelet S, Hovnanian A, Bondet V, Duffy D, Ungeheuer MN, Delage M, Nassif A, Di Santo JP, Demangel C. Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa. JCI Insight 2020;5:140598. [PMID: 32970636 DOI: 10.1172/jci.insight.140598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
81 Narla S, Azzam M, Townsend S, Vellaichamy G, Marzano AV, Alavi A, Lowes MA, Hamzavi IH. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils. Br J Dermatol 2021;184:1004-13. [PMID: 32893875 DOI: 10.1111/bjd.19538] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
82 van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. Br J Dermatol 2012;166:298-305. [PMID: 22013960 DOI: 10.1111/j.1365-2133.2011.10698.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
83 Zouboulis CC. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa. Expert Review of Clinical Immunology 2016;12:1015-26. [DOI: 10.1080/1744666x.2016.1221762] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Tsaousi A, Witte E, Witte K, Röwert-Huber HJ, Volk HD, Sterry W, Wolk K, Schneider-Burrus S, Sabat R. MMP8 Is Increased in Lesions and Blood of Acne Inversa Patients: A Potential Link to Skin Destruction and Metabolic Alterations. Mediators Inflamm 2016;2016:4097574. [PMID: 27843200 DOI: 10.1155/2016/4097574] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
85 Campanati A, Orciani M, Sorgentoni G, Consales V, Offidani A, Di Primio R. Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa. JAMA Dermatol 2018;154:1184-90. [PMID: 30140888 DOI: 10.1001/jamadermatol.2018.2516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
86 Ghoreschi K, Balato A, Enerbäck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 2021;397:754-66. [PMID: 33515492 DOI: 10.1016/S0140-6736(21)00184-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 13.0] [Reference Citation Analysis]
87 Frew JW, Marzano AV, Wolk K, Join-lambert O, Alavi A, Lowes MA, Piguet V. A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance. Journal of Investigative Dermatology 2021;141:316-324.e2. [DOI: 10.1016/j.jid.2020.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
88 Mizoguchi A. Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis. 2012;18:1777-1784. [PMID: 22359410 DOI: 10.1002/ibd.22929] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 9.2] [Reference Citation Analysis]
89 Wozniak KL, Hole CR, Yano J, Fidel PL, Wormley FL. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection. Microbiology (Reading) 2014;160:1440-52. [PMID: 24760968 DOI: 10.1099/mic.0.073445-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
90 Navrazhina K, Garcet S, Gonzalez J, Grand D, Frew JW, Krueger JG. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes. J Invest Dermatol 2021;141:2197-207. [PMID: 33766512 DOI: 10.1016/j.jid.2021.02.742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
91 Yu R, Ding Y, Zhu L, Qu Y, Zhang C, Liu L, Chen L. IL-22 mediates the oral mucosal wound healing via STAT3 in keratinocytes. Archives of Oral Biology 2016;72:14-20. [DOI: 10.1016/j.archoralbio.2016.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
92 Wolk K, Brembach T, Šimaitė D, Bartnik E, Cucinotta S, Pokrywka A, Irmer M, Triebus J, Witte‐händel E, Salinas G, Leeuw T, Volk H, Ghoreschi K, Sabat R. Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*. Br J Dermatol 2021;185:164-76. [DOI: 10.1111/bjd.19795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
93 Del Duca E, Morelli P, Bennardo L, Di Raimondo C, Nisticò SP. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. Int J Mol Sci 2020;21:E8436. [PMID: 33182701 DOI: 10.3390/ijms21228436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
94 Schneider-Burrus S, Tsaousi A, Barbus S, Huss-Marp J, Witte K, Wolk K, Fritz B, Sabat R. Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients. Front Med (Lausanne) 2021;8:676241. [PMID: 33987196 DOI: 10.3389/fmed.2021.676241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 Matusiak Ł. The end of the beginning or the beginning of the end? Br J Dermatol 2018;179:14-5. [PMID: 30156275 DOI: 10.1111/bjd.16058] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
96 Cho CG, Gong SH, Kim H, Song J, Park JH, Lim Y, Park S. Role of group 3 innate lymphoid cells during experimental otitis media in a rat model. International Journal of Pediatric Otorhinolaryngology 2016;88:146-52. [DOI: 10.1016/j.ijporl.2016.07.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
97 Jenei A, Dajnoki Z, Medgyesi B, Gáspár K, Béke G, Kinyó Á, Méhes G, Hendrik Z, Dinya T, Törőcsik D, Zouboulis CC, Prens EP, Bíró T, Szegedi A, Kapitány A. Apocrine Gland-Rich Skin Has a Non-Inflammatory IL-17-Related Immune Milieu, that Turns to Inflammatory IL-17-Mediated Disease in Hidradenitis Suppurativa. J Invest Dermatol 2019;139:964-8. [PMID: 30391261 DOI: 10.1016/j.jid.2018.10.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
98 Deckers IE, van der Zee HH, Prens EP. Epidemiology of Hidradenitis Suppurativa: Prevalence, Pathogenesis, and Factors Associated with the Development of HS. Curr Derm Rep 2014;3:54-60. [DOI: 10.1007/s13671-013-0064-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
99 Kokolakis G, Wolk K, Schneider-Burrus S, Kalus S, Barbus S, Gomis-Kleindienst S, Sabat R. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System. Dermatology 2020;236:421-30. [PMID: 32610312 DOI: 10.1159/000508787] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
100 Lim C, Hong M, Savan R. Human IL-22 binding protein isoforms act as a rheostat for IL-22 signaling. Sci Signal 2016;9:ra95-ra95. [DOI: 10.1126/scisignal.aad9887] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
101 Reddy S, Strunk A, Garg A. Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa. JAMA Dermatol 2019;155:797-802. [PMID: 30994865 DOI: 10.1001/jamadermatol.2019.0164] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
102 Dessinioti C, Katsambas A, Antoniou C. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol. 2014;32:397-408. [PMID: 24767187 DOI: 10.1016/j.clindermatol.2013.11.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
103 von Haehling S, Wolk K, Höflich C, Kunz S, Grünberg BH, Döcke WD, Reineke U, Asadullah K, Sterry W, Volk HD, Sabat R. Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms. Genes Immun 2015;16:8-14. [PMID: 25472783 DOI: 10.1038/gene.2014.69] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
104 Melnik BC, Plewig G. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol. 2013;22:172-177. [PMID: 23489419 DOI: 10.1111/exd.12098] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
105 Matusiak Ł, Jemec GB, Szepietowski JC. Pharmacological development in hidradenitis suppurativa. Current Opinion in Pharmacology 2019;46:65-72. [DOI: 10.1016/j.coph.2019.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
106 Yamamoto T. Pyoderma gangrenosum: An important dermatologic condition occasionally associated with rheumatic diseases. WJR 2015;5:101. [DOI: 10.5499/wjr.v5.i2.101] [Cited by in CrossRef: 3] [Article Influence: 0.5] [Reference Citation Analysis]
107 Solimani F, Meier K, Ghoreschi K. Emerging Topical and Systemic JAK Inhibitors in Dermatology. Front Immunol 2019;10:2847. [PMID: 31849996 DOI: 10.3389/fimmu.2019.02847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 26.0] [Reference Citation Analysis]
108 Karagiannidis I, Nikolakis G, Sabat R, Zouboulis CC. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord 2016;17:335-41. [DOI: 10.1007/s11154-016-9366-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
109 Brosch S, Dietze-Schwonberg K, Lopez Kostka S, Lorenz B, Haak S, Becher B, von Stebut E. Disease control in cutaneous leishmaniasis is independent of IL-22. J Invest Dermatol 2015;135:308-11. [PMID: 24999596 DOI: 10.1038/jid.2014.282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
110 Shanmugam VK, Zaman NM, McNish S, Hant FN. Review of Current Immunologic Therapies for Hidradenitis Suppurativa. Int J Rheumatol 2017;2017:8018192. [PMID: 28912816 DOI: 10.1155/2017/8018192] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
111 Chan LC, Chaili S, Filler SG, Barr K, Wang H, Kupferwasser D, Edwards JE Jr, Xiong YQ, Ibrahim AS, Miller LS, Schmidt CS, Hennessey JP Jr, Yeaman MR. Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus. Infect Immun 2015;83:4427-37. [PMID: 26351278 DOI: 10.1128/IAI.01061-15] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
112 Kelhälä HL, Palatsi R, Fyhrquist N, Lehtimäki S, Väyrynen JP, Kallioinen M, Kubin ME, Greco D, Tasanen K, Alenius H, Bertino B, Carlavan I, Mehul B, Déret S, Reiniche P, Martel P, Marty C, Blume-Peytavi U, Voegel JJ, Lauerma A. IL-17/Th17 pathway is activated in acne lesions. PLoS One 2014;9:e105238. [PMID: 25153527 DOI: 10.1371/journal.pone.0105238] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 10.1] [Reference Citation Analysis]
113 Campione E, Lanna C, Diluvio L, Cannizzaro MV, Grelli S, Galluzzo M, Talamonti M, Annicchiarico-Petruzzelli M, Mancini M, Melino G, Candi E, Schiavone G, Wang Y, Shi Y, Bianchi L. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo. Cell Cycle 2020;19:257-67. [PMID: 31905036 DOI: 10.1080/15384101.2019.1707455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
114 Scala E, Di Caprio R, Cacciapuoti S, Caiazzo G, Fusco A, Tortorella E, Fabbrocini G, Balato A. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26. Br J Dermatol 2019;181:1038-45. [PMID: 30829398 DOI: 10.1111/bjd.17854] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
115 Kumari S, Bonnet MC, Ulvmar MH, Wolk K, Karagianni N, Witte E, Uthoff-Hachenberg C, Renauld JC, Kollias G, Toftgard R, Sabat R, Pasparakis M, Haase I. Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice. Immunity 2013;39:899-911. [PMID: 24211183 DOI: 10.1016/j.immuni.2013.10.009] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 12.6] [Reference Citation Analysis]
116 Hotz C, Boniotto M, Guguin A, Surenaud M, Jean-Louis F, Tisserand P, Ortonne N, Hersant B, Bosc R, Poli F, Bonnabau H, Thiébaut R, Godot V, Wolkenstein P, Hocini H, Lévy Y, Hüe S. Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. J Invest Dermatol 2016;136:1768-80. [PMID: 27206704 DOI: 10.1016/j.jid.2016.04.036] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 14.6] [Reference Citation Analysis]
117 Maarouf M, Clark AK, Lee DE, Shi VY. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. Journal of Dermatological Treatment 2018;29:441-9. [DOI: 10.1080/09546634.2017.1395806] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
118 Clark RA. Human skin in the game. Sci Transl Med 2013;5:204ps13. [PMID: 24068735 DOI: 10.1126/scitranslmed.3007504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
119 Dispenza MC, Wolpert EB, Gilliland KL, Dai JP, Cong Z, Nelson AM, Thiboutot DM. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol 2012;132:2198-205. [PMID: 22513780 DOI: 10.1038/jid.2012.111] [Cited by in Crossref: 97] [Cited by in F6Publishing: 68] [Article Influence: 10.8] [Reference Citation Analysis]
120 Valeri M, Raffatellu M. Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis 2016;74:ftw111. [PMID: 27915228 DOI: 10.1093/femspd/ftw111] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 14.4] [Reference Citation Analysis]
121 Walker CR, Hautefort I, Dalton JE, Overweg K, Egan CE, Bongaerts RJ, Newton DJ, Cruickshank SM, Andrew EM, Carding SR. Intestinal intraepithelial lymphocyte-enterocyte crosstalk regulates production of bactericidal angiogenin 4 by Paneth cells upon microbial challenge. PLoS One. 2013;8:e84553. [PMID: 24358364 DOI: 10.1371/journal.pone.0084553] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
122 Yamazaki Y, Yamada M, Kawai T, Morio T, Onodera M, Ueki M, Watanabe N, Takada H, Takezaki S, Chida N, Kobayashi I, Ariga T. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody. J Immunol 2014;193:4880-7. [PMID: 25288569 DOI: 10.4049/jimmunol.1401467] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
123 Jończyk-Matysiak E, Weber-Dąbrowska B, Żaczek M, Międzybrodzki R, Letkiewicz S, Łusiak-Szelchowska M, Górski A. Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes. Front Microbiol 2017;8:164. [PMID: 28228751 DOI: 10.3389/fmicb.2017.00164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
124 Gold DA, Reeder VJ, Mahan MG, Hamzavi IH. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J Am Acad Dermatol 2014;70:699-703. [PMID: 24433875 DOI: 10.1016/j.jaad.2013.11.014] [Cited by in Crossref: 111] [Cited by in F6Publishing: 88] [Article Influence: 15.9] [Reference Citation Analysis]
125 Wollina U, Tilp M, Meseg A, Schönlebe J, Heinig B, Nowak A. Management of Severe Anogenital Acne Inversa (Hidradenitis Suppurativa). Dermatologic Surgery 2012;38:110-7. [DOI: 10.1111/j.1524-4725.2011.02157.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
126 Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 2020;183:999-1010. [PMID: 33048349 DOI: 10.1111/bjd.19556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
127 Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020;6:18. [PMID: 32165620 DOI: 10.1038/s41572-020-0149-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 56.0] [Reference Citation Analysis]
128 Ellis LZ. Hidradenitis Suppurativa: Surgical and Other Management Techniques. Dermatologic Surgery 2012;38:517-36. [DOI: 10.1111/j.1524-4725.2011.02186.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]